Arkolith/Insider Trading/STRO/Form 4

Fitzpatrick Linda A

CHIEF PEOPLE & COMM. OFFICERSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed May 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)9K—$0105K
May 1, 2025Option exercise(M)10K—$0114K
May 1, 2025Tax withholding(F)14K$1.07$14K120K
May 1, 2025Option exercise(M)6K—$0133K
May 1, 2025Option exercise(M)13K—$0127K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)9K—$00
May 1, 2025Option exercise(M)6K—$07K
May 1, 2025Option exercise(M)13K—$015K
May 1, 2025Option exercise(M)10K—$04K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-011998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML